BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28330535)

  • 1. [Advantages and disadvantages of direct-to-consumer genetic tests].
    Christiansen CW; Gerdes AA
    Ugeskr Laeger; 2017 Mar; 179(11):. PubMed ID: 28330535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct-to-consumer genetic testing: a systematic review of european guidelines, recommendations, and position statements.
    Rafiq M; Ianuale C; Ricciardi W; Boccia S
    Genet Test Mol Biomarkers; 2015 Oct; 19(10):535-47. PubMed ID: 26313927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'It's much more grey than black and white': clinical geneticists' views on the oversight of consumer genomics in Europe.
    Kalokairinou L; Borry P; Howard HC
    Per Med; 2020 Mar; 17(2):129-140. PubMed ID: 32154757
    [No Abstract]   [Full Text] [Related]  

  • 4. [Direct-to-consumer genetic testing: a regulation by the market, or a medical regulation?].
    Jautrou H
    Med Sci (Paris); 2020 Feb; 36(2):153-159. PubMed ID: 32129752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct-to-consumer genetic testing for predicting sports performance and talent identification: Consensus statement.
    Webborn N; Williams A; McNamee M; Bouchard C; Pitsiladis Y; Ahmetov I; Ashley E; Byrne N; Camporesi S; Collins M; Dijkstra P; Eynon N; Fuku N; Garton FC; Hoppe N; Holm S; Kaye J; Klissouras V; Lucia A; Maase K; Moran C; North KN; Pigozzi F; Wang G
    Br J Sports Med; 2015 Dec; 49(23):1486-91. PubMed ID: 26582191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct-to-consumer Genetic Testing: Changes in the EU Regulatory Landscape.
    Slokenberga S
    Eur J Health Law; 2015 Dec; 22(5):463-80. PubMed ID: 26665691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the legislation of direct-to-consumer genetic testing in EU member states.
    Hoxhaj I; Stojanovic J; Sassano M; Acampora A; Boccia S
    Eur J Med Genet; 2020 Apr; 63(4):103841. PubMed ID: 31923586
    [No Abstract]   [Full Text] [Related]  

  • 8. [Not Available].
    Erlandsson R
    Lakartidningen; 2018 Mar; 115():. PubMed ID: 29558008
    [No Abstract]   [Full Text] [Related]  

  • 9. Direct-to-consumer misleading information on cancer risks calls for an urgent clarification of health genetic testing performed by commercial companies.
    de Pauw A; Schwartz M; Colas C; Golmard L; Stoppa-Lyonnet D
    Eur J Cancer; 2020 Jun; 132():100-103. PubMed ID: 32335476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current landscape of direct-to-consumer genetic testing and its role in ophthalmology: a review.
    Sanfilippo PG; Kearns LS; Wright P; Mackey DA; Hewitt AW
    Clin Exp Ophthalmol; 2015 Aug; 43(6):578-90. PubMed ID: 25676199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. “Better Not to Know?”: Justifiable Limits on the Right to Information in the Realm of DTC Genetic Testing. An Analysis of the European and Spanish Legal Framework.
    Martínez Otero JM
    Eur J Health Law; 2017 Apr; 24(2):175-97. PubMed ID: 29210260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of direct-to-consumer genetic testing for complex disease in diagnostics and research.
    Burdon KP
    Clin Exp Ophthalmol; 2015 Aug; 43(6):503-4. PubMed ID: 26223155
    [No Abstract]   [Full Text] [Related]  

  • 13. Direct-to-Consumer Genetic Testing: The Implications of the US FDA's First Marketing Authorization for BRCA Mutation Testing.
    Gill J; Obley AJ; Prasad V
    JAMA; 2018 Jun; 319(23):2377-2378. PubMed ID: 29800087
    [No Abstract]   [Full Text] [Related]  

  • 14. Direct-to-Consumer Genetic Testing and Potential Loopholes in Protecting Consumer Privacy and Nondiscrimination.
    Hendricks-Sturrup RM; Prince AER; Lu CY
    JAMA; 2019 May; 321(19):1869-1870. PubMed ID: 30998825
    [No Abstract]   [Full Text] [Related]  

  • 15. Patients Armed With Their Own Genetic Data Raise Tough Questions.
    Storrs C
    Health Aff (Millwood); 2018 May; 37(5):690-693. PubMed ID: 29733706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are providers prepared for genomic medicine: interpretation of Direct-to-Consumer genetic testing (DTC-GT) results and genetic self-efficacy by medical professionals.
    McGrath SP; Walton N; Williams MS; Kim KK; Bastola K
    BMC Health Serv Res; 2019 Nov; 19(1):844. PubMed ID: 31760949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct-to-Consumer Genetic Testing: Helping Patients Make Informed Choices.
    Mahon SM
    Clin J Oncol Nurs; 2018 Feb; 22(1):33-36. PubMed ID: 29350705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Food and drug administration's regulatory shift on direct-to-consumer genetic tests for cancer risk.
    Yang YT; Zettler PJ
    Cancer; 2019 Jan; 125(1):12-14. PubMed ID: 30387874
    [No Abstract]   [Full Text] [Related]  

  • 19. New EU Rules for In Vitro Diagnostic Genetic Tests, a First Step in the Right Direction.
    Roscam Abbing HDC
    Eur J Health Law; 2017 Apr; 24(2):121-33. PubMed ID: 29210257
    [No Abstract]   [Full Text] [Related]  

  • 20. Genotype-directed therapy and age-related-macular degeneration: a cautionary note.
    Grosso A; Marchese C; Arias L; Panico C; Sigler E
    Clin Exp Ophthalmol; 2015; 43(7):700-2. PubMed ID: 25894836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.